Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
At-Home Drug of Abuse market report explains the definition, types, applications, major countries, and major players of the At-Home Drug of Abuse market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Waters Corporation
Shimadzu Corporation
Danaher Corporation
MilliporeSigma
Roche
Psychemedics Corporation
BioMerieux
Drägerwerk
Siemens AG
Express Diagnostics
By Type:
Consumable
Equipment
By End-User:
Urine
Saliva
Hair
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global At-Home Drug of Abuse Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 At-Home Drug of Abuse Outlook to 2028- Original Forecasts
-
2.2 At-Home Drug of Abuse Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term At-Home Drug of Abuse Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global At-Home Drug of Abuse Market- Recent Developments
-
6.1 At-Home Drug of Abuse Market News and Developments
-
6.2 At-Home Drug of Abuse Market Deals Landscape
7 At-Home Drug of Abuse Raw Materials and Cost Structure Analysis
-
7.1 At-Home Drug of Abuse Key Raw Materials
-
7.2 At-Home Drug of Abuse Price Trend of Key Raw Materials
-
7.3 At-Home Drug of Abuse Key Suppliers of Raw Materials
-
7.4 At-Home Drug of Abuse Market Concentration Rate of Raw Materials
-
7.5 At-Home Drug of Abuse Cost Structure Analysis
-
7.5.1 At-Home Drug of Abuse Raw Materials Analysis
-
7.5.2 At-Home Drug of Abuse Labor Cost Analysis
-
7.5.3 At-Home Drug of Abuse Manufacturing Expenses Analysis
8 Global At-Home Drug of Abuse Import and Export Analysis (Top 10 Countries)
-
8.1 Global At-Home Drug of Abuse Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global At-Home Drug of Abuse Export by Region (Top 10 Countries) (2017-2028)
9 Global At-Home Drug of Abuse Market Outlook by Types and Applications to 2022
-
9.1 Global At-Home Drug of Abuse Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Consumable Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Equipment Consumption and Growth Rate (2017-2022)
-
9.2 Global At-Home Drug of Abuse Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Urine Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Saliva Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hair Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise At-Home Drug of Abuse Market Analysis and Outlook till 2022
-
10.1 Global At-Home Drug of Abuse Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States At-Home Drug of Abuse Consumption (2017-2022)
-
10.2.2 Canada At-Home Drug of Abuse Consumption (2017-2022)
-
10.2.3 Mexico At-Home Drug of Abuse Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.2 UK At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.3 Spain At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.4 Belgium At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.5 France At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.6 Italy At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.7 Denmark At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.8 Finland At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.9 Norway At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.10 Sweden At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.11 Poland At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.12 Russia At-Home Drug of Abuse Consumption (2017-2022)
-
10.3.13 Turkey At-Home Drug of Abuse Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.2 Japan At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.3 India At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.4 South Korea At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.5 Pakistan At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.6 Bangladesh At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.7 Indonesia At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.8 Thailand At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.9 Singapore At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.10 Malaysia At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.11 Philippines At-Home Drug of Abuse Consumption (2017-2022)
-
10.4.12 Vietnam At-Home Drug of Abuse Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil At-Home Drug of Abuse Consumption (2017-2022)
-
10.5.2 Colombia At-Home Drug of Abuse Consumption (2017-2022)
-
10.5.3 Chile At-Home Drug of Abuse Consumption (2017-2022)
-
10.5.4 Argentina At-Home Drug of Abuse Consumption (2017-2022)
-
10.5.5 Venezuela At-Home Drug of Abuse Consumption (2017-2022)
-
10.5.6 Peru At-Home Drug of Abuse Consumption (2017-2022)
-
10.5.7 Puerto Rico At-Home Drug of Abuse Consumption (2017-2022)
-
10.5.8 Ecuador At-Home Drug of Abuse Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain At-Home Drug of Abuse Consumption (2017-2022)
-
10.6.2 Kuwait At-Home Drug of Abuse Consumption (2017-2022)
-
10.6.3 Oman At-Home Drug of Abuse Consumption (2017-2022)
-
10.6.4 Qatar At-Home Drug of Abuse Consumption (2017-2022)
-
10.6.5 Saudi Arabia At-Home Drug of Abuse Consumption (2017-2022)
-
10.6.6 United Arab Emirates At-Home Drug of Abuse Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria At-Home Drug of Abuse Consumption (2017-2022)
-
10.7.2 South Africa At-Home Drug of Abuse Consumption (2017-2022)
-
10.7.3 Egypt At-Home Drug of Abuse Consumption (2017-2022)
-
10.7.4 Algeria At-Home Drug of Abuse Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia At-Home Drug of Abuse Consumption (2017-2022)
-
10.8.2 New Zealand At-Home Drug of Abuse Consumption (2017-2022)
11 Global At-Home Drug of Abuse Competitive Analysis
-
11.1 Waters Corporation
-
11.1.1 Waters Corporation Company Details
-
11.1.2 Waters Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Waters Corporation At-Home Drug of Abuse Main Business and Markets Served
-
11.1.4 Waters Corporation At-Home Drug of Abuse Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Shimadzu Corporation
-
11.2.1 Shimadzu Corporation Company Details
-
11.2.2 Shimadzu Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Shimadzu Corporation At-Home Drug of Abuse Main Business and Markets Served
-
11.2.4 Shimadzu Corporation At-Home Drug of Abuse Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Danaher Corporation
-
11.3.1 Danaher Corporation Company Details
-
11.3.2 Danaher Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Danaher Corporation At-Home Drug of Abuse Main Business and Markets Served
-
11.3.4 Danaher Corporation At-Home Drug of Abuse Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 MilliporeSigma
-
11.4.1 MilliporeSigma Company Details
-
11.4.2 MilliporeSigma At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 MilliporeSigma At-Home Drug of Abuse Main Business and Markets Served
-
11.4.4 MilliporeSigma At-Home Drug of Abuse Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Roche
-
11.5.1 Roche Company Details
-
11.5.2 Roche At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Roche At-Home Drug of Abuse Main Business and Markets Served
-
11.5.4 Roche At-Home Drug of Abuse Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Psychemedics Corporation
-
11.6.1 Psychemedics Corporation Company Details
-
11.6.2 Psychemedics Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Psychemedics Corporation At-Home Drug of Abuse Main Business and Markets Served
-
11.6.4 Psychemedics Corporation At-Home Drug of Abuse Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 BioMerieux
-
11.7.1 BioMerieux Company Details
-
11.7.2 BioMerieux At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 BioMerieux At-Home Drug of Abuse Main Business and Markets Served
-
11.7.4 BioMerieux At-Home Drug of Abuse Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Drägerwerk
-
11.8.1 Drägerwerk Company Details
-
11.8.2 Drägerwerk At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Drägerwerk At-Home Drug of Abuse Main Business and Markets Served
-
11.8.4 Drägerwerk At-Home Drug of Abuse Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Siemens AG
-
11.9.1 Siemens AG Company Details
-
11.9.2 Siemens AG At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Siemens AG At-Home Drug of Abuse Main Business and Markets Served
-
11.9.4 Siemens AG At-Home Drug of Abuse Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Express Diagnostics
-
11.10.1 Express Diagnostics Company Details
-
11.10.2 Express Diagnostics At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Express Diagnostics At-Home Drug of Abuse Main Business and Markets Served
-
11.10.4 Express Diagnostics At-Home Drug of Abuse Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global At-Home Drug of Abuse Market Outlook by Types and Applications to 2028
-
12.1 Global At-Home Drug of Abuse Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Consumable Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Equipment Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global At-Home Drug of Abuse Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Urine Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Saliva Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Hair Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise At-Home Drug of Abuse Market Analysis and Outlook to 2028
-
13.1 Global At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.2.2 Canada At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.2.3 Mexico At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.2 UK At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.3 Spain At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.4 Belgium At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.5 France At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.6 Italy At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.7 Denmark At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.8 Finland At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.9 Norway At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.10 Sweden At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.11 Poland At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.12 Russia At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.3.13 Turkey At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.2 Japan At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.3 India At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.4 South Korea At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.5 Pakistan At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.7 Indonesia At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.8 Thailand At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.9 Singapore At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.10 Malaysia At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.11 Philippines At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.4.12 Vietnam At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5.2 Colombia At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5.3 Chile At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5.4 Argentina At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5.5 Venezuela At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5.6 Peru At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.5.8 Ecuador At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.6.2 Kuwait At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.6.3 Oman At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.6.4 Qatar At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.7.2 South Africa At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.7.3 Egypt At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.7.4 Algeria At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia At-Home Drug of Abuse Consumption Forecast (2022-2028)
-
13.8.2 New Zealand At-Home Drug of Abuse Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of At-Home Drug of Abuse
-
Figure of At-Home Drug of Abuse Picture
-
Table Global At-Home Drug of Abuse Import by Region (Top 10 Countries) (2017-2028)
-
Table Global At-Home Drug of Abuse Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Consumable Consumption and Growth Rate (2017-2022)
-
Figure Global Equipment Consumption and Growth Rate (2017-2022)
-
Figure Global Urine Consumption and Growth Rate (2017-2022)
-
Figure Global Saliva Consumption and Growth Rate (2017-2022)
-
Figure Global Hair Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Table North America At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Figure United States At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Canada At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Mexico At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Table Europe At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Figure Germany At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure UK At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Spain At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Belgium At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure France At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Italy At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Denmark At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Finland At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Norway At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Sweden At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Poland At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Russia At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Turkey At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Table APAC At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Figure China At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Japan At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure India At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure South Korea At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Pakistan At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Indonesia At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Thailand At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Singapore At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Malaysia At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Philippines At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Vietnam At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Table South America At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Figure Brazil At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Colombia At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Chile At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Argentina At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Venezuela At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Peru At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Ecuador At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Table GCC At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Figure Bahrain At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Kuwait At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Oman At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Qatar At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Table Africa At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Figure Nigeria At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure South Africa At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Egypt At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure Algeria At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Table Oceania At-Home Drug of Abuse Consumption by Country (2017-2022)
-
Figure Australia At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Figure New Zealand At-Home Drug of Abuse Consumption and Growth Rate (2017-2022)
-
Table Waters Corporation Company Details
-
Table Waters Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Waters Corporation At-Home Drug of Abuse Main Business and Markets Served
-
Table Waters Corporation At-Home Drug of Abuse Product Portfolio
-
Table Shimadzu Corporation Company Details
-
Table Shimadzu Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shimadzu Corporation At-Home Drug of Abuse Main Business and Markets Served
-
Table Shimadzu Corporation At-Home Drug of Abuse Product Portfolio
-
Table Danaher Corporation Company Details
-
Table Danaher Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Corporation At-Home Drug of Abuse Main Business and Markets Served
-
Table Danaher Corporation At-Home Drug of Abuse Product Portfolio
-
Table MilliporeSigma Company Details
-
Table MilliporeSigma At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table MilliporeSigma At-Home Drug of Abuse Main Business and Markets Served
-
Table MilliporeSigma At-Home Drug of Abuse Product Portfolio
-
Table Roche Company Details
-
Table Roche At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche At-Home Drug of Abuse Main Business and Markets Served
-
Table Roche At-Home Drug of Abuse Product Portfolio
-
Table Psychemedics Corporation Company Details
-
Table Psychemedics Corporation At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Psychemedics Corporation At-Home Drug of Abuse Main Business and Markets Served
-
Table Psychemedics Corporation At-Home Drug of Abuse Product Portfolio
-
Table BioMerieux Company Details
-
Table BioMerieux At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMerieux At-Home Drug of Abuse Main Business and Markets Served
-
Table BioMerieux At-Home Drug of Abuse Product Portfolio
-
Table Drägerwerk Company Details
-
Table Drägerwerk At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Drägerwerk At-Home Drug of Abuse Main Business and Markets Served
-
Table Drägerwerk At-Home Drug of Abuse Product Portfolio
-
Table Siemens AG Company Details
-
Table Siemens AG At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens AG At-Home Drug of Abuse Main Business and Markets Served
-
Table Siemens AG At-Home Drug of Abuse Product Portfolio
-
Table Express Diagnostics Company Details
-
Table Express Diagnostics At-Home Drug of Abuse Sales, Price, Value and Gross Profit (2017-2022)
-
Table Express Diagnostics At-Home Drug of Abuse Main Business and Markets Served
-
Table Express Diagnostics At-Home Drug of Abuse Product Portfolio
-
Figure Global Consumable Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Equipment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Saliva Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hair Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Table North America At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Figure United States At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Figure Germany At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure France At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Figure China At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure India At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Table South America At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Figure Brazil At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Figure Bahrain At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Figure Nigeria At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania At-Home Drug of Abuse Consumption Forecast by Country (2022-2028)
-
Figure Australia At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand At-Home Drug of Abuse Consumption Forecast and Growth Rate (2022-2028)
-
